<qa>  How many weeks will Subjects receive subcutaneous injections of Golimumab or placeboSubjects will receive subcutaneous injections of either 50 or 100 mg Golimumab or placebo every two or four weeks or an infusion of infliximab at week 20, 22, 28, 36, 44 for 48 weeks 